These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14703580)

  • 1. [Can we afford the costs of progress in intensive care medicine? A plea for a candid debate].
    Boldt J
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):36-40. PubMed ID: 14703580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expensive modern therapy options in intensive care medicine in Germany-- are they being used? Results of a questionnaire].
    Boldt J; Papsdorf M
    Dtsch Med Wochenschr; 2005 Jan; 130(3):87-91. PubMed ID: 15650957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost analysis concerning MRSA-infection in ICU].
    Geldner G; Ruoff M; Hoffmann HJ; Kiefer P; Georgieff M; Wiedeck H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jul; 34(7):409-13. PubMed ID: 10464519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economics and outcome in the intensive care unit.
    Pittoni GM; Scatto A
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):232-6. PubMed ID: 19390250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost evaluation of patients with severe sepsis in intensive care units.
    Piacevoli Q; Palazzo F; Azzeri F
    Minerva Anestesiol; 2004 Jun; 70(6):453-71. PubMed ID: 15235553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic aspects of intensive care medicine--cost and reimbursement according to diagnosis related grouping].
    Billing A; Thalhammer M; Eissner HJ; Jauch KW; Inthorn D
    Zentralbl Chir; 2004 Dec; 129(6):440-6. PubMed ID: 15616906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical imperative versus economic consequence: exploring the cost burden and opportunities in the care of patients with sepsis.
    Merritt CL
    Nurs Adm Q; 2011; 35(1):61-7. PubMed ID: 21157265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possibilities for cost containment in intensive care.
    Thungjaroenkul P; Kunaviktikul W
    Nurs Health Sci; 2006 Dec; 8(4):237-40. PubMed ID: 17081150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Staphylococcal infections as an important problem in intensive therapy--own clinical observations].
    Czaban SL; Olszańska D; Siemiatkowski A
    Przegl Lek; 2006; 63(7):529-32. PubMed ID: 17203802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit.
    Gould IM; MacKenzie FM; MacLennan G; Pacitti D; Watson EJ; Noble DW
    Int J Antimicrob Agents; 2007 May; 29(5):536-43. PubMed ID: 17337163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calculation of costs per inpatient day in an intensive care unit].
    Alvear V S; Canteros J; Rodríguez P
    Rev Med Chil; 2010 May; 138(5):558-66. PubMed ID: 20668810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding cost-effectiveness in the ICU.
    Zilberberg MD
    Semin Respir Crit Care Med; 2010 Feb; 31(1):13-8. PubMed ID: 20101543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The incidence and cost of severe sepsis in intensive care units].
    Csomós A; Hoffer G; Fülesdi B; Ludwig E
    Orv Hetil; 2005 Jul; 146(29):1543-7. PubMed ID: 16136776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis Related Groups in intensive care units--cost model for critically ill patients].
    Andersen JS; Drenck NE; Keiding H
    Ugeskr Laeger; 2007 Feb; 169(8):727-30. PubMed ID: 17313929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and efficiency of intensive care medicine: variable costs in different diagnosis groups.
    Iapichino G; Radrizzani D; Simini B; Rossi C; Albicini M; Ferla L; Colombo A; Pezzi A; Brazzi L; Melotti R; Rossi G;
    Acta Anaesthesiol Scand; 2004 Aug; 48(7):820-6. PubMed ID: 15242425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genuine progress in intensive care medicine must be payable also in future--a plea for a public debate].
    Reinhart K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Apr; 39(4):187-90. PubMed ID: 15098165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.